Suchitra Sundaram, MD, reviews new data on CLL treatments presented at ASH 2024, highlighting exciting possibilities for future patient care. She recounts the case of a 75-year-old man with worsening ...
Javier Pinilla-Ibarz, MD, PhD: In terms of diagnosis and prognosis for chronic lymphocytic leukemia, we initially have to perform a technique called flow cytometry that will really indicate the ...
Two distinct subtypes, U-CLL C1 and U-CLL C2, were identified within IGHV-unmutated chronic lymphocytic leukemia, showing unique epigenetic and genetic profiles. U-CLL C1 is enriched for ATM deletions ...
Patterns of hepatitis B reactivation and liver test abnormalities in patients with chronic lymphocytic leukemia (CLL) treated with idelalisib plus an anti-CD20 antibody. Checkmate 205: Nivolumab (nivo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results